LSPediA LLC, a leading software and service provider for the pharmaceutical industry, today announced an agreement with TG United and its affiliated company TG United Liquid Inc, privately owned pharmaceutical manufacturers that specialize in a wide range of solid- and liquid-dose products.
By leveraging LSPediA’s RxChain solution, TG United will enable serial data management, packaging aggregation, serialized shipping, and EPCIS data exchanges with trading partners. These system capabilities support the efforts of TG United and its affiliated companies to comply with FDA DSCSA regulations for their current product lines and future product launches.
“Manufacturers like TG United face not only business challenges but compliance challenges,” said Riya Cao, LSPediA CEO. “The ability to meet FDA compliance standards while also driving business efficiency is the key to success in the competitive pharmaceutical market place. By providing a robust serialization platform, we take on the heavy lifting associated with serialized operations so our customers can focus on their core business and future growth.”
About TG United
TG United, Inc. was formed in 2005 as a privately owned manufacturing company. Based in Brooksville, Florida, the company manufactures a wide range of solid-dose products including tablets and capsules in compliance with the OTC monograph. They are also the exclusive distributor of a single-source liquid statin prescription drug product. TG United is dedicated to meeting customers’ needs regarding the manufacturing of solid-dose products, and undergoes audits by the FDA, DEA and the Florida Department of Health.
About LSPediA – Life Sciences Solutions
LSPediA is a leading provider of enterprise software and services designed for pharmaceutical manufacturers, wholesale distributors, and dispensers. With LSPediA, customers can better implement serialization and aggregation processes to meet global regulations, DSCSA requirements, and future track-and-trace mandates.